BioCardia, Inc.
BCDA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000925741
In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in BioCardia, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +2 vs. Q1 2022
- Shares held
- 2.14M
- −513.7K (−19.4%) vs. Q1 2022
- Total value
- $3.10M
- −$2.38M (−43.4%) vs. Q1 2022
- New holders
- 4
- 5 more added
- Sold out
- 2
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BCDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 21 | $1.65M |
| Q1 2026 | 18 | $831.1K |
| Q4 2025 | 20 | $812.3K |
| Q3 2025 | 18 | $551.9K |
| Q2 2025 | 16 | $593.2K |
| Q1 2025 | 12 | $623.8K |
| Q4 2024 | 13 | $272.2K |
| Q3 2024 | 9 | $316.6K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 22 | $790.8K |
| Q4 2023 | 24 | $1.37M |
| Q3 2023 | 16 | $709.6K |
| Q2 2023 | 23 | $4.43M |
| Q1 2023 | 23 | $4.09M |
| Q4 2022 | 25 | $4.87M |
| Q3 2022 | 23 | $3.17M |
| Q2 2022 | 26 | $3.10M |
| Q1 2022 | 24 | $5.49M |
| Q4 2021 | 23 | $5.78M |
| Q3 2021 | 22 | $9.01M |
| Q2 2021 | 20 | $12.3M |
| Q1 2021 | 19 | $13.5M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding BioCardia, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Captrust Financial Advisors | 660,637 | $958.0K | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 650,523 | $943.0K | 0.00% | 00.0% | Unchanged |
| CM Management, LLC | 329,000 | $477.0K | 0.51% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 108,842 | $161.0K | 0.00% | +36,514+50.5% | Added |
| Geode Capital Management, LLC | 91,365 | $135.0K | 0.00% | +3,810+4.4% | Added |
| Commonwealth Equity Services, LLC | 49,978 | $72.0K | 0.00% | 00.0% | Unchanged |
| Brown Advisory Inc | 33,085 | $48.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 31,843 | $46.0K | 0.00% | −2,645−7.7% | Reduced |
| Millennium Management LLC | 28,312 | $42.0K | 0.00% | +28,312 | New |
| Dimensional Fund Advisors LP | 27,407 | $41.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 21,000 | $31.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 19,226 | $28.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,675 | $26.0K | 0.00% | −26,020−59.5% | Reduced |
| Renaissance Technologies LLC | 14,800 | $21.0K | 0.00% | +1,100+8.0% | Added |
| Bank of New York Mellon Corp | 12,767 | $19.0K | 0.00% | −87−0.7% | Reduced |
| Cetera Investment Advisers | 12,610 | $18.0K | 0.00% | +12,610 | New |
| LPL Financial LLC | 11,050 | $16.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 6,528 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 4,974 | $7.00K | 0.00% | +3,280+193.6% | Added |
| Simplex Trading, LLC | 2,260 | $3.00K | 0.00% | −595−20.8% | Reduced |
| Morgan Stanley | 983 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 900 | $1.00K | 0.00% | −100−10.0% | Reduced |
| Tower Research Capital LLC (TRC) | 758 | $1.00K | 0.00% | +758 | New |
| Wells Fargo & Company | 78 | $0 | 0.00% | +8+11.4% | Added |
| Aspire Private Capital, LLC | 300 | $0 | 0.00% | +300 | New |
| IFP Advisors, Inc | 100 | – | – | 00.0% | Unchanged |
| Roumell Asset Management, LLC | 0 | $0 | 0.00% | −536,497−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −34,431−100.0% | Sold out |